Covid-19 Reignites Push to Make IV Drugs Easier to Get at Home

April 28, 2020, 9:51 AM UTC

Home health agencies and lawmakers are calling for a policy change to certain Medicare benefits to let more patients who need lifesaving IV drugs get those medications at home during the coronavirus outbreak.

Enabling more at-home drug infusions would protect people at high risk for severe complications, such as the elderly or immuno-compromised, and help hospitals around the country clear space for Covid-19 patients.

But while the federal Medicare agency has relaxed a host of other regulations to make it easier for doctors and nurses to combat the pandemic, it hasn’t taken action to make it easy enough for patients ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.